Laddar...
Delivering safer immunotherapies for cancer
Cancer immunotherapy is now a powerful clinical reality, with a steady progression of new drug approvals and a massive pipeline of additional treatments in clinical and preclinical development. However, modulation of the immune system can be a double-edged sword: Drugs that activate immune effectors...
Sparad:
| I publikationen: | Adv Drug Deliv Rev |
|---|---|
| Huvudupphovsmän: | , , |
| Materialtyp: | Artigo |
| Språk: | Inglês |
| Publicerad: |
2017
|
| Ämnen: | |
| Länkar: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5647831/ https://ncbi.nlm.nih.gov/pubmed/28545888 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.addr.2017.05.011 |
| Taggar: |
Lägg till en tagg
Inga taggar, Lägg till första taggen!
|